Akodio Therapeutics is focused on developing monoclonal antibodies and drug conjugates for the treatment of various neurological conditions, including multiple sclerosis, Alzheimer's disease, and long COVID
Akodio Therapeutics is focused on developing monoclonal antibodies and drug conjugates for the treatment of various neurological conditions, including multiple sclerosis, Alzheimer's disease, and long COVID.